Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dunaliella Bardawil for Low HDL Cholesterol
NCT00156169Phase 3Completed
- Sponsor
- Sheba Medical Center
- Start
- May 2001
- Modality
- Botanical Extract
01
Overview
Phase 3 trial of Dunaliella bardawil in low hdl cholesterol and hypertriglyceridemia, sponsored by Sheba Medical Center. Started May 2001; status: completed.
02
Drugs
Dunaliella bardawil
03
Conditions
low hdl cholesterolhypertriglyceridemia
Beyond the preview
Go deeper on NCT00156169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156169.